Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Elsa, Solà"'
Autor:
Laura Napoleone, Cristina Solé, Adrià Juanola, Ann T. Ma, Marta Carol, Martina Pérez‐Guasch, Ana‐Belén Rubio, Marta Cervera, Emma Avitabile, Octavi Bassegoda, Jordi Gratacós‐Ginès, Manuel Morales‐Ruiz, Núria Fabrellas, Isabel Graupera, Elisa Pose, Gonzalo Crespo, Elsa Solà, Pere Ginès
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 2121-2131 (2022)
Abstract Impairment of kidney function is common in acute‐on‐chronic liver failure (ACLF). Patterns of kidney dysfunction and their impact on kidney and patient outcomes are ill‐defined. Aims of the current study were to investigate patterns of
Externí odkaz:
https://doaj.org/article/3bbac5b05fdb45e484727170b93d6048
Autor:
Elisa Pose, Elsa Solà, Juan J. Lozano, Adrià Juanola, Julia Sidorova, Giacomo Zaccherini, Koos deWit, Frank Uschner, Marta Tonon, Konstantin Kazankov, Cesar Jiménez, Daniela Campion, Laura Napoleone, Ann T. Ma, Marta Carol, Manuel Morales‐Ruiz, Carlo Alessandria, Ulrich Beuers, Paolo Caraceni, Claire Francoz, François Durand, Rajeshwar P. Mookerjee, Jonel Trebicka, Victor Vargas, Salvatore Piano, Hugh Watson, Juan G. Abraldes, Patrick S. Kamath, Mark M. Davis, Pere Ginès, for the investigators of the LIVERHOPE Consortium
Publikováno v:
Hepatology Communications, Vol 6, Iss 5, Pp 1100-1112 (2022)
Patients with decompensated cirrhosis, particularly those with acute‐on‐chronic liver failure (ACLF), show profound alterations in plasma metabolomics. The aim of this study was to investigate the effect of treatment with simvastatin and rifaximi
Externí odkaz:
https://doaj.org/article/ef91c857b6d7462f9f2e68c608047196
Autor:
Isabel Graupera, Laura Isus, Mar Coll, Elisa Pose, Alba Díaz, Julia Vallverdú, Teresa Rubio-Tomás, Celia Martínez-Sánchez, Patricia Huelin, Marta Llopis, Cristina Solé, Elsa Solà, Constantino Fondevila, Juan José Lozano, Pau Sancho-Bru, Pere Ginès, Patrick Aloy
Publikováno v:
JHEP Reports, Vol 4, Iss 6, Pp 100482- (2022)
Background & Aims: The molecular mechanisms driving the progression from early-chronic liver disease (CLD) to cirrhosis and, finally, acute-on-chronic liver failure (ACLF) are largely unknown. Our aim was to develop a protein network-based approach t
Externí odkaz:
https://doaj.org/article/4d279b50e65d4f14a2a246d30b4f3ba4
Autor:
Marta Carol, Martina Pérez-Guasch, Elsa Solà, Marta Cervera, Sara Martínez, Adrià Juanola, Ann T Ma, Emma Avitabile, Laura Napoleone, Elisa Pose, Isabel Graupera, Maria Honrubia, Marko Korenjak, Ferran Torres, Pere Ginès, Núria Fabrellas, LiverHope Consortium Investigators
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0265153 (2022)
Background and aimsStigmatization is a well-documented problem of some diseases. Perceived stigma is common in alcohol-related liver disease and hepatitis C, but little information exists on stigma in patients with non-alcoholic fatty liver disease (
Externí odkaz:
https://doaj.org/article/0769501c19ab4938bfcea01cbf08bf41
Autor:
Delia Blaya, Elisa Pose, Mar Coll, Juan José Lozano, Isabel Graupera, Robert Schierwagen, Christian Jansen, Pedro Castro, Sara Fernandez, Julia Sidorova, Mariuca Vasa-Nicotera, Elsa Solà, Joan Caballería, Jonel Trebicka, Pere Ginès, Pau Sancho-Bru
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100233- (2021)
Background & Aims: MicroRNAs (miRNAs) circulate in several body fluids and can be useful biomarkers. The aim of this study was to identify blood-circulating miRNAs associated with cirrhosis progression and acute-on-chronic liver failure (ACLF). Metho
Externí odkaz:
https://doaj.org/article/b58b7a66ed174809bfc0f1e51931249b
Autor:
Annarein J. C. Kerbert, Hein W. Verspaget, Àlex Amorós Navarro, Rajiv Jalan, Elsa Solà, Daniel Benten, François Durand, Pere Ginès, Johan J. van der Reijden, Bart van Hoek, Minneke J. Coenraad, for the CANONIC Study Investigators of the EASL-CLIF Consortium
Publikováno v:
Critical Care, Vol 21, Iss 1, Pp 1-11 (2017)
Abstract Background Acute-on-chronic liver failure (ACLF) is characterized by the presence of acute decompensation (AD) of cirrhosis, organ failure, and high short-term mortality rates. Hemodynamic dysfunction and activation of endogenous vasoconstri
Externí odkaz:
https://doaj.org/article/65fbae07ec7b4cfeb818b44d824cfa09
Autor:
Isabel Graupera, Mar Coll, Elisa Pose, Chiara Elia, Salvatore Piano, Elsa Solà, Delia Blaya, Patricia Huelin, Cristina Solé, Rebeca Moreira, Gloria de Prada, Núria Fabrellas, Adrià Juanola, Manuel Morales-Ruiz, Pau Sancho-Bru, Càndid Villanueva, Pere Ginès
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Fatty-acid-binding proteins (FABPs) are small intracellular proteins that coordinate lipid-mediated processes by targeting metabolic and immune response pathways. The aim of the study was to investigate plasma FABPs levels and their relation
Externí odkaz:
https://doaj.org/article/525a30fc94354712b2baef14a0ab7259
Autor:
Manuel Morales-Ruiz, Marta Carol, Wladimiro Jiménez, Octavi Bassegoda, Isabel Graupera, Ann T. Ma, Adrià Juanola, Salvatore Piano, Núria Fabrellas, Laia Escudé, Martina Pérez-Guasch, Elisa Pose, Pere Ginès, Marta Cervera, Cristina Solé, Gonzalo Crespo, Chiara Elia, Ferran Torres, Ana-Belén Rubio, Elsa Solà, Emma Avitabile, Laura Napoleone
Publikováno v:
Journal of Hepatology. 76:107-114
Decompensated cirrhosis (DC) is associated with high mortality, mainly owing to the development of acute-on-chronic liver failure (ACLF). Identifying the patients with DC who are at high risk of mortality and ACLF development is an unmet clinical nee
Autor:
Núria Fabrellas, Rosario Hernández, Isabel Graupera, Elsa Solà, Pilar Ramos, Natividad Martín, Gemma Sáez, Consuelo Simón, Almudena Pérez, Teresa Graell, Andrea Larrañaga, Manel Garcia, Ana de la Arada, Adrià Juanola, Alicia Coiduras, Isabel Duaso, Angel Casado, Julian Martin, Marta Ginès, Nuria Moreno, Ana Gema Perez, Laia Marti, Mireia Bernat, Montse Sola, Carmina Olivé, Cristina Solé, Pere Ginès
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0200656 (2018)
BACKGROUND:Primary care is the ideal setting for early identification of patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is a potentially progressive disease that may lead to cirrhosis and liver cancer but is frequently underrecognized
Externí odkaz:
https://doaj.org/article/55c9161240e34050bd6a4d497db325a6
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:1473-1474